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ahe Berlin Heart EXCOR ventricular assist device (Berlin
Heart AG, Berlin, Germany) was developed to support
hildren awaiting cardiac transplantation1 and since 2005
as been used increasingly in North America.2-4 The EXCOR
s a pneumatically driven pulsatile device, capable of sup-
orting the left ventricle or both ventricles. Although the
ajority of children in whom the device has been used have
ad either dilated cardiomyopathy or myocarditis, at least
5% have structural congenital heart disease.5 Many of the
rinciples important to the implantation procedure of the
erlin Heart apply to all etiologies of heart failure, but for
hildren with structural heart disease, there are certain spe-
ial considerations. In particular, there is an absolute require-
ent for complete septation of the heart, so that there is no
ossibility of right-to-left shunting during the active suction
hase of left ventricular assist device (LVAD) pump diastole.
ikewise, it is crucial that the native semilunar valves of the
ecipient be competent. Thus, for patients with severe aortic
r pulmonary valve insufficiency, replacement of the incom-
etent valve at the time of VAD implantation should be con-
idered. Although atrioventricular valve competence is also
esirable, it is probably not necessary to repair the mitral or
ricuspid valve at the time of ventricular assist device (VAD)
lacement. As with any patient in need of mechanical cardiac
upport, a major consideration is whether LVAD support
lonewill be adequate or whether a biventricular assist device
BiVAD) implantation will be necessary. This decision will
ften be made intraoperatively, and so preparation for both
ptions should be made. In some cases, implantation of a
ompetent semilunar valve in the right ventricular outflow
ract may increase right ventricular efficiency enough that
VAD support alone is adequate. Additional preparation for
evice implantation includes the performance of preopera-
ive transesophageal echocardiogram with specific focus on
he presence of intracardiac shunts (patent foramen ovale,
esidual ventricular septal defects, etc), semilunar valve func-
ion, and the presence of thrombus in the left ventricle.
The first step in the conduct of the implant operation is the
dentification of exit sites for the VAD cannulas (Fig. 1). The
perative field and skin preparation should be, to borrow
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doi:10.1053/j.optechstcvs.2010.03.005rom folk singer Loudon Wainwright III, “High, Wide, and
andsome,” extending from the pubis to the neck and from
idaxillary line to midaxillary line, with provision made for
emoral cannulation if needed. For children with extensive
rior medical histories, there may be a gastrostomy tube, a
acemaker or implantable cardioverter-defibrillator, or other
hysical sequelae of prior operative interventions, and corre-
ponding alterations in cannula location may be required.
fter routine skin preparation and draping, the areas of pro-
osed cannula skin exit should be marked on the skin. The
onsiderations in choosing skin exit sites include the need for
he Dacron cuff on each cannula to extend at least 1 cm
eyond the skin exit, the need for a separation of at least 2 cm
etween the costal margin and the exit site, and
he desirability of avoiding the “VAD in lap syndrome.” Be-
ause the pump size will determine the cannula size, it is
ossible and helpful to open the cannulas and lay them out in
he proposed configuration(s) in choosing skin exit sites.
The next step is to open (or reopen) the chest via sternot-
my. If there has been prior cardiac surgery, all the usual
autions for redo sternotomy apply. With the sternum open,
t is helpful to create the LVAD cannula tunnels before the
dministration of heparin, making every effort to avoid entry
nto the peritoneum. As a general principle, the cannula tun-
els should be slightly smaller than the cannulas, to avoid
xcessive cannula motion after implantation and to facilitate
issue ingrowth into the Dacron cuffs.
Preliminary dissection in the chest must obviously be tem-
ered by the degree of hemodynamic stability of the recipi-
nt, but in general it is preferable to do as much dissection as
ossible before heparinization and the initiation of cardio-
ulmonary bypass. The cannulation strategy for cardiopul-
onary bypass should include placement of the arterial can-
ula as far distally as possible on the aorta to facilitate
lacement of the LVAD outflow cannula on the ascending
orta. (In the event that the patient is being transitioned from
xtracorporeal membrane oxygenation (ECMO) to VAD sup-
ort, the ECMO arterial cannula will suffice; new aortic can-
ulation is unnecessary.) Bicaval venous cannulation should
lways be used, both to facilitate any intracardiac procedure
s well as to maximize the flexibility for right atrial cannula-
ion should BiVAD support be necessary. The left heart
hould be decompressed by means of a vent catheter placed
t the junction of the right upper pulmonary vein and the left


















































































Berlin Heart implantation for congenital heart defects 163lete mobilization of the heart should be accomplished. This
tep is necessary to allow elevation of the left ventricular apex
or placement of the LVAD inflow cannula.
After completion of mobilization of the heart, any adjunc-
ive procedure is accomplished before beginning VAD can-
ula implantation. In some cases, this will involve cardiople-
ic arrest of the heart such as for atrial septal defect or
entricular septal defect closure. In other cases, such as pul-
onary valve implantation, this can be accomplished with
he heart still perfused and beating (Fig. 2).
Implantation of VAD cannulas begins with the insertion of
he LVAD inflow cannula, which is placed in the left ventric-
lar apex (Fig. 3). This portion of the procedure can be done
ith the heart beating or with the heart arrested. In either
ase, placement of a laparotomy sponge behind the heart will
acilitate exposure. If possible, flooding the operative field
ith carbon dioxide gas during the portions of the proce-
ures during which the cardiac chambers are open may be
elpful in subsequent de-airing. The first step in LVAD im-
igure 1 Cannula skin exit sites are demonstrated, as are potential
kin sites for RVAD cannulas (denoted as “X” in the drawing). Note
hat there would be overlap of the two systems in the event of BiVAD
upport. Also illustrated is the VAD-in-lap syndrome, which may be
navoidable, particularly in the smallest patients.lantation is to excise a circular, transmural core from the cpex of the ventricle, just anterior to the apical dimple.With the
entricle open, the cavity shouldbe inspected for thepresence of
hrombus, which if present should be meticulously and com-
letely removed. Next, a series of horizontal mattress, pledget-
einforcedmonofilament sutures are brought transmurally from
utside to inside on the ventricular wall, and then up through
he flange on the apical cannula. The cannula is then lowered
nto the ventricular cavity, and the sutures are tied. Next a
ircular hole is cut in the middle of a large sheet of 0.1-mm-
hickness polytetrafluoroethylene (PTFE), and the cannula is
rought through this sheet. (The sheet is placed to minimize
dhesion formation between the ventricle and the pericar-
ium.) Then the cannula is drawn through the previously
reated tunnel (Fig. 4). This maneuver can be accomplished
n a variety of ways ranging from simply forcefully pulling the
annula through the tunnel with a large clamp to placing the
annula in the flared end of a chest tube, which is first drawn
hrough the passage. With the cannula brought through the
ody wall, the left-sided vent is clamped and removed. The
ent line can then be placed in the lumen of the left ventric-
lar apical cannula until the blood pump is ready to be at-
ached.
The next cannula to be implanted is the aortic cannula if an
VAD-only strategy is to be employed (Fig. 5). Unlike the
pical cannula, the aorta cannula is brought through the
ody wall before attachment to the patient. After tunneling
he cannula, the attachment to the aorta may be accom-
lished with either the aorta completely clamped or the seg-
ent to be cannulated isolated in the jaws of a partial occlusion
lamp. The former approach is much simpler technically, and
he latter approach is really only feasible if the aorta is very
arge. The cannulation site is ideally sited slightly laterally on
he ascending aorta if possible, using a longitudinal aorto-
omy. The mode of attachment of the aortic cannula to the
orta depends on the size of the cannula. Smaller sized can-
ulas are fabricated with a flared and coated protrusion,
hich extends into the aortic lumen. With this cannula de-
ign, two concentric purse-string sutures are used to snug the
all of the aorta around the flared end of the cannula. In the
arger cannula sizes, there is no protruding tip, and the can-
ula is simply anastomosed to the aortotomy with a contin-
ous monofilament suture. After completion of the attach-
ent of the cannula to the aorta, the cross-clamp (or partial
cclusion clamp) is removed, and the ascending aorta is
ented into the cannula.
In LVAD-only implantation, the next step is to attach the
annulas to the blood pump and begin de-airing the system.
efore this, the pump will have been filled with saline, and
low ventilation is commenced to expel air from the left-
ided cardiac chambers. The blood pump is then attached
o the cannulas, while aspirating from the pump chamber
ith the premounted blunt needle (Fig. 6). Until de-airing is
ompleted, the LVAD aortic cannula is left clamped. With
ompletion of de-airing confirmed by transesophageal echo-
ardiography, as well as meticulous inspection of the VAD
hamber and cannulas, LVAD pumping is commenced. Full
entilation is initiated, and cardiopulmonary bypass is slowly
eaned, continuing echocardiographic visualization to de-
ect residual intracardiac air. Continuous direct inspection of
he transparent blood pump chamber is also mandatory to be
ertain of the adequacy of de-airing.
164 R.D.B. Jaquiss and M. ImamuraFigure 2 (A) In a patient with severe pulmonary insufficiency after prior transannular repair of tetralogy of Fallot, the
original transannular patch has been removed in preparation for insertion of a bioprosthetic valve to establish valvar
competence. The remnants of the original pulmonary valve are visible on the posterior right ventricular outflow tract.
(B) A stented bioprosthetic valve has been seated in the right ventricular outflow tract, with the posterior portion of the
sewing ring secured in place with a continuous monofilament suture. The valve is seated at the level of the original
native pulmonary valve annulus. (C) With the bioprosthetic valve seated and secured posteriorly, a generous anterior
transannular patch is prepared from a piece of bovine pericardium. The patch should be fashioned in an oval shape and
then folded on itself, as shown in the illustration. Post.  posterior; PV  pulmonary vein.
Berlin Heart implantation for congenital heart defects 165Figure 2 (Continued) (D) The folded edge of the patch is then sewn to the anterior, uncovered portion of the valve sewing
ring with a continuous suture, which is in turn tied to the end of the suture used to secure the valve posteriorly. (E) The
patch is then unfolded and secured with a continuous suture to the pulmonary artery wall and the infundibulum. If
RVAD placement is needed, the RVAD outflow cannula can be placed into the distal portion of the transannular patch,
and the patch should be constructed with this possibility inmind. The area for potential cannulation is shown as a circle
on the transannular patch. (F) In this diagram, the bioprosthetic valve has been implanted, and a transannular patch is
used to re-create the anterior wall of the pulmonary artery. In this case, an RVAD outflow cannula is shown being
anastomosed to the pulmonary artery. In other cases, establishment of pulmonary valve competence may increase right
heart efficiency enough to allow for LVAD support alone.
166 R.D.B. Jaquiss and M. ImamuraFigure 3 (A) Placement of the inflow cannula for the LVAD is accomplished in the left ventricular apex, anterior to the
apical dimple. Exposure is facilitated by placement of a laparotomy sponge behind the heart to elevate the cardiac apex.
After removal of a core of apical muscle, a series of horizontal mattress, pledget-reinforced sutures are brought through
the ventricular wall and up through the flange on the apical cannula. The bevel on the cannula should be oriented
toward the ventricular septum. (B) A critical portion of LVAD apical cannula placement is inspection of the left
ventricular cavity, looking formural thrombus, which should bemeticulously and completely removed if present. If the
patient has a prosthetic mitral valve in place, the potential for clot formation on the mechanical valve should be
considered and the valve inspected. (C) The appearance of completed left ventricular apical cannulation. LAD  left
anterior descending coronary artery; LV  left ventricle.
Berlin Heart implantation for congenital heart defects 167Figure 4 After insertion of the cannula in the left ventricular apex, the cannula has been drawn through the previously
created tunnel. Note that the Dacron cuff extends well beyond the skin exit site.
168 R.D.B. Jaquiss and M. ImamuraFigure 5 (A) Attachment of the LVAD outflow cannula to the aorta is demonstrated. (For clarity, the superior vena cava
cannula has been omitted from the figure.) It should be noted that the aortic cannula, unlike the apical cannula, is
brought through the bodywall before attachment to the aorta. In planning for placement of the aortic cannula, it should
be remembered that this portion of the procedure is facilitated if the aortic cannulation site for cardiopulmonary bypass
is placed as far distally as possible. After application of the aortic cross-clamp and administration of antegrade
cardioplegia, the cardioplegia catheter (which was placed at the site of planned VAD cannula attachment) is removed.
An appropriate aortotomy is fashioned and the LVAD cannula is attached. (B) For smaller patients, the aortic cannula
has a flared, coated end, designed to protrude slightly into the aortic lumen. Attachment to the cannula is accomplished
by placement of two concentric purse-string sutures around the margin of the aortotomy, as shown in (A). The ends of
the sutures are then brought up through the flange of the cannula, approximately 180° apart. The flared end is then
inserted into the aorta and the sutures are tied down securely on the flange, which snugs the aortic wall tightly around
the end of the cannula. (C) For larger children, an aortic cannula with no intraluminal projection is employed. For this














Berlin Heart implantation for congenital heart defects 169As separation from bypass is accomplished, attention is
aid to the adequacy of LVAD filling, best assessed by inspec-
ion of the excursion of the diaphragm in the blood pump.
ecause of the magnitude of the negative intracardiac pres-
ure that is created by pump diastole, intracardiac pressure-
onitoring lines should be avoided because of the risk of
Figure 6 (A) An important feature of the Berlin Heart blo
hub is cannulated with a blunt needle during setup and p
a ligature, as shown in the inset. After attachment of the
ligature is cut and the needle is removed. (B) The de-air
with the flexible diaphragm separating the pneumatic c
between the diaphragm at maximum excursion and the
flexible, however, and care should be taken not to distor
the diaphragm.ntrainment of air into the heart (and blood pump). If inspec- wion of the LVAD blood pump suggests inadequate filling,
his is generally a reflection of either relative hypovolemia or
nadequate right heart function. In the former case, judicious
dministration of volume will normalize pump filling. In the
atter case, support of the dysfunctional right ventricle with
nhaled nitric oxide and appropriate inotropic medications
mp is the presence of a de-airing hub. This self-sealing
of the pump, and the needle is secured to the hub with
pump to the cannulas and completion of de-airing, the
dle is relatively short, so that it cannot come in contact
r from the blood chamber. (In the figure, the distance
f the needle is exaggerated.) The blood pump casing is










































170 R.D.B. Jaquiss and M. Imamuralearly inadequate, cardiopulmonary bypass is re-established
nd a right ventricular assist device (RVAD) is implanted.
Implantation of the RVAD begins with placement of the
ulmonary artery cannula. As with the aortic cannula, this is
rst passed through the body wall. Attachment is then made
o the distal main pulmonary artery in a fashion similar to
hat for the aortic cannula. It is important that the pulmonary
rtery cannula be positioned so as to avoid distortion of the
ulmonary valve for obvious reasons. Next the inflow can-
ula for the RVAD is brought through the body wall before
ttachment to the right atrium. Atrial attachment is then ac-
omplished with placement of two concentric purse-string
utures, which are brought through and tied down on the
ange of the atrial cannula, snugging the atrial tissue around
he cannula in a fashion analogous to that employed with the
maller sized aortic cannulas (Fig. 7). The right heart is then
llowed to fill for de-airing by reducing cardiopulmonary
ypass flow slightly. After cannula de-airing is completed,
Figure 7 If an RVAD is to be implanted, the pulmonar
attached to the distal main pulmonary artery (not sho
cannula. Finally, the right atrial cannula is brought thro
wall of the right atrium. The right atrial cannula is sim
intracavitary projection. As with aortic cannulation wit
placed around the right atriotomy and brought up throu
into the body of the right atrium, the sutures are tied dow
the cannula.ttachment is made to the RVAD pump, which is in turn ce-aired. BiVAD pumping is then initiated, and the patient is
eparated from bypass after establishment of full ventilation.
After the adequacy of LVAD or BiVAD filling and function
s assured, protamine reversal of heparinization is accom-
lished and bypass (or ECMO) cannulas are removed. Al-
hough complete hemostasis is part of all cardiac surgical
rocedures, it is particularly important in VAD patients, as
heywill be fully anticoagulatedwithin a few days after device
mplantation. Before chest closure, the sheet of PTFE around
he ventricular apex is positioned to prevent formation of
dhesions between the heart and pericardial surfaces. Judi-
ious placement of additional pieces of PTFE membrane be-
ween the aorta and pulmonary artery, lateral to the right
trium, and anterior to the innominate vein and VAD cannu-
as, will make re-entry at the time of transplant both more
apid and safer. With hemostasis complete and PTFE mem-
rane strategically positioned, the chest is closed in a routine
ashion, after placement of large-diameter chest tubes. In rare
y cannula is brought through the body wall and then
a manner analogous to the attachment of the aortic
e body wall and attached to the midportion of the free
the smaller aortic cannulas in that it has a significant
aller cannula, two concentric purse-string sutures are
flange on the atrial cannula. After inserting the cannula

















Berlin Heart implantation for congenital heart defects 171enuous, or if right ventricular function is marginal, the chest
an be left open, with a sterile dressing anteriorly, and closed
ater under more satisfactory hemostatic and hemodynamic
ircumstances.
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